Acute and Subclinical Myocardial Injury in COVID-19

Valentina L. Crudo; Ahmed I. Ahmed; Eilidh L. Cowan; Dipan J. Shah; Mouaz H. Al-Mallah; Maan Malahfji

doi:10.14797/mdcvj.1038

Acute and Subclinical Myocardial Injury in COVID-19

Valentina L. Crudo, Ahmed I. Ahmed, Eilidh L. Cowan, Dipan J. Shah, Mouaz H. Al-Mallah, Maan Malahfji

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients-with or without established cardiovascular disease-incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.

Original language	English (US)
Pages (from-to)	22-30
Number of pages	9
Journal	Methodist DeBakey cardiovascular journal
Volume	17
Issue number	5
DOIs	https://doi.org/10.14797/mdcvj.1038
State	Published - 2021

Keywords

COVID-19
cardiovascular disease
coronavirus
myocardial injury
myocarditis

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.14797/mdcvj.1038

Cite this

@article{d835a9f6a48b4716965a4699e59c7d8f,

title = "Acute and Subclinical Myocardial Injury in COVID-19",

abstract = "Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients-with or without established cardiovascular disease-incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.",

keywords = "COVID-19, cardiovascular disease, coronavirus, myocardial injury, myocarditis",

author = "Crudo, {Valentina L.} and Ahmed, {Ahmed I.} and Cowan, {Eilidh L.} and Shah, {Dipan J.} and Al-Mallah, {Mouaz H.} and Maan Malahfji",

note = "Publisher Copyright: Copyright: {\textcopyright} 2021 The Author(s).",

year = "2021",

doi = "10.14797/mdcvj.1038",

language = "English (US)",

volume = "17",

pages = "22--30",

journal = "Methodist DeBakey cardiovascular journal",

issn = "1947-6094",

publisher = "Methodist DeBakey Heart & Vascular Center",

number = "5",

}

TY - JOUR

T1 - Acute and Subclinical Myocardial Injury in COVID-19

AU - Crudo, Valentina L.

AU - Ahmed, Ahmed I.

AU - Cowan, Eilidh L.

AU - Shah, Dipan J.

AU - Al-Mallah, Mouaz H.

AU - Malahfji, Maan

PY - 2021

Y1 - 2021

N2 - Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients-with or without established cardiovascular disease-incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.

AB - Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients-with or without established cardiovascular disease-incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.

KW - COVID-19

KW - cardiovascular disease

KW - coronavirus

KW - myocardial injury

KW - myocarditis

UR - http://www.scopus.com/inward/record.url?scp=85123269309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123269309&partnerID=8YFLogxK

U2 - 10.14797/mdcvj.1038

DO - 10.14797/mdcvj.1038

M3 - Review article

C2 - 34992721

AN - SCOPUS:85123269309

SN - 1947-6094

VL - 17

SP - 22

EP - 30

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

IS - 5

ER -

Acute and Subclinical Myocardial Injury in COVID-19

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this